Data Foundry

Drug recalls 2026

Clear Eyes Redness Relief — Class II drug recall D-0870-2026

Ongoing recall by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, reported 2026-09-30, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0870-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmInsight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY, United States
Recall initiated2026-09-15
Classified2026-09-23
Reported by FDA2026-09-30
DistributedNationwide (US)
Quantity2,356,248 bottles
Reason classessterility
NDC67172-0797-15
Lot numbersAUG-27, JUL-27, NOV-27, OCT-27, RL25G02, RL25G03, RL25G04, RL25H02, RL25H03, RL25H04, RL25K01, RL25K02, RL25K03, RL25K04, RL25M01, RL25M02, RL25M03, RL25M04, RL25N01, RL25N02, RL25N04, SEP-27

Product

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0870-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-06. Not affiliated with or endorsed by FDA. Not medical or legal advice.